MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-03-2025
Castle Biosciences Total Shareholders Equity 2011-2026 | CSTL
Annual Total Shareholders Equity Castle Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 456 M | 391 M | 399 M | 412 M | 416 M | 85.1 M | -56.6 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 456 M | -56.6 M | 300 M |
Quarterly Total Shareholders Equity Castle Biosciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 467 M | 455 M | 440 M | 456 M | 441 M | 424 M | 402 M | 391 M | 386 M | 379 M | 385 M | 399 M | 411 M | 422 M | 397 M | 412 M | 412 M | 416 M | 419 M | 416 M | 416 M | 416 M | 416 M | 85.1 M | 85.1 M | 85.1 M | 85.1 M | -56.6 M | -56.6 M | -56.6 M | -53.9 M | -50.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 467 M | -56.6 M | 301 M |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
5.39 B | $ 116.01 | 0.41 % | $ 35.3 B |  USA |
|
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-22.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Illumina
ILMN
|
2.37 B | $ 128.01 | 0.11 % | $ 20.4 B | USA |
 |
Co-Diagnostics
CODX
|
20.6 M | $ 1.66 | -0.4 % | $ 2.21 M | USA |
 |
Aspira Women's Health
AWH
|
-6.93 M | - | -6.19 % | $ 10.5 M | USA |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 84.39 | 0.07 % | $ 5.7 B | USA |
 |
Medpace Holdings
MEDP
|
459 M | $ 415.9 | 1.3 % | $ 12 B | USA |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
11.9 B | $ 27.62 | 0.55 % | $ 20 B |  Niderland |
 |
Check-Cap Ltd.
CHEK
|
-1.45 M | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
303 M | $ 21.54 | 1.46 % | $ 1.15 B | USA |
 |
Senseonics Holdings
SENS
|
61 M | $ 7.08 | 0.35 % | $ 295 M | USA |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
Soleno Therapeutics
SLNO
|
450 M | $ 52.72 | - | $ 2.68 B | USA |
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
1.13 B | $ 15.92 | -2.42 % | $ 481 M | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M |  China |
 |
Thermo Fisher Scientific
TMO
|
53.4 B | $ 468.84 | -0.16 % | $ 177 B | USA |
 |
Genetic Technologies Limited
GENE
|
16.4 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.69 B | - | 0.12 % | $ 80.1 M | China |
 |
Trinity Biotech plc
TRIB
|
-2.22 M | $ 0.64 | -1.51 % | $ 61.9 M |  Irlanda |
 |
Charles River Laboratories International
CRL
|
3.16 B | $ 173.7 | 2.3 % | $ 8.61 B | USA |
 |
Twist Bioscience Corporation
TWST
|
473 M | $ 60.47 | -0.77 % | $ 3.62 B | USA |
 |
Guardant Health
GH
|
-99.3 M | $ 89.62 | 0.79 % | $ 11.2 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
22.4 M | $ 1.91 | -3.29 % | $ 8.45 M | USA |
 |
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | Israel |
 |
QIAGEN N.V.
QGEN
|
3.78 B | - | - | $ 10.6 B | Niderland |
 |
Neogen Corporation
NEOG
|
2.07 B | $ 9.51 | -0.37 % | $ 2.06 B | USA |
 |
Biomerica
BMRA
|
4.1 M | $ 2.16 | 0.93 % | $ 4.96 M | USA |
 |
National Research Corporation
NRC
|
14 M | $ 17.17 | -0.35 % | $ 384 M | USA |
 |
ICON Public Limited Company
ICLR
|
9.52 B | $ 99.66 | -2.46 % | $ 8.22 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
8.62 B | $ 263.45 | -0.13 % | $ 21.9 B | USA |
 |
Celcuity
CELC
|
101 M | $ 123.57 | 2.1 % | $ 5.78 B | USA |
 |
OpGen
OPGN
|
7.38 M | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
837 M | $ 8.55 | 3.08 % | $ 1.1 B | USA |
 |
Myriad Genetics
MYGN
|
368 M | $ 4.77 | -0.21 % | $ 442 M | USA |
 |
Natera
NTRA
|
706 M | $ 205.15 | 0.69 % | $ 20.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.17 B | $ 196.64 | 0.22 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
102 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
7.25 B | - | -0.91 % | $ 14.7 B | USA |